DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by VELA Investment Management LLC

VELA Investment Management LLC cut its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 38.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 49,101 shares of the medical instruments supplier's stock after selling 31,019 shares during the period. VELA Investment Management LLC's holdings in DENTSPLY SIRONA were worth $932,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Pacer Advisors Inc. boosted its holdings in DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after buying an additional 4,473,972 shares in the last quarter. JPMorgan Chase & Co. boosted its position in DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after purchasing an additional 1,244,326 shares in the last quarter. Invenomic Capital Management LP purchased a new stake in shares of DENTSPLY SIRONA in the third quarter valued at approximately $23,724,000. National Bank of Canada FI lifted its position in shares of DENTSPLY SIRONA by 85.8% during the 3rd quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier's stock valued at $44,059,000 after buying an additional 751,800 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of DENTSPLY SIRONA by 50.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier's stock valued at $55,900,000 after buying an additional 692,100 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday. Mizuho assumed coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 price target on the stock. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Friday. Leerink Partners cut DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Finally, UBS Group dropped their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research report on Tuesday, December 3rd. Eleven analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $23.58.

DENTSPLY SIRONA Stock Down 2.4 %

XRAY stock traded down $0.39 during mid-day trading on Tuesday, reaching $15.61. The company had a trading volume of 2,433,137 shares, compared to its average volume of 2,564,472. DENTSPLY SIRONA Inc. has a fifty-two week low of $15.47 and a fifty-two week high of $34.28. The company has a market capitalization of $3.10 billion, a price-to-earnings ratio of -7.53, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a fifty day simple moving average of $18.77 and a 200 day simple moving average of $21.39.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.10%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.